Archive for November, 2009

Potent Blend Of Treatments Combats Breast Tumors
Potent Blend Of Treatments Combats Breast Tumors
At the conclusion of the decade old, coast-to-coast survey on women having a rare type of breast cancer, Richard J. Barth Jr., M.D., and three associate researchers are composing the case for a particular blend of treatments for halting the tumors prior to metastasis. In the Aug-09 edition of the Annals of Surgical Oncology, Barth, an associate professor of surgery at Dartmouth Medical School (DMS) and his associates along with Wendy Wells, M.D. – a professor of pathology in DMS suggest employing adjunct radiotherapy on those patients that underwent breast-preservation surgery for controlling borderline malignant and malignant phyllodes tumors. The follow-ups done on the improvement in 46 women that were given follow-up radiotherapy in thirty diverse organizations in eighteen states, the  [...]

November 30th, 2009 | Breast Cancer
Vulval Cancer
Vulval Cancer
Vulval Cancer is a cancer type that could affect any part of the exteriorly placed female sex organs. The inner edging of the labia majora and the labia minora are the commonly affected areas for its development. Less frequently, cancer could also affect the clitoris, or the Bartholin glands that are the tiny glands located one on either side of the vagina. Cancer could additionally develop in the perineum. Types of Vulval Cancer Squamous Cell Carcinoma 9 out of 10 vulvar cancers starting developing in the skin of the vulva from the cells known as squamous cells. This form of vulvar cancer develops in a gradual course of several years. Vulval Melanoma Melanomas developing from the pigment-creating cells that proffer the skin its colour. Vulval melanoma is the second most prevalent form of  [...]

November 30th, 2009 | Vulval Cancer
LLLT Could Lead To Aggravations In Skin Cancer
LLLT Could Lead To Aggravations In Skin Cancer
High beam radiations of LLLT or low-level laser therapy must ideally not be employed over melanomas. Researchers that have written in the open access journal BMC Cancer evaluated the pain and inflammation allaying ‘cold laser’ and found that it lead to heightened tumour development in a mouse model of skin cancer. Jan M. Bjordal at the University College in Norway teamed up with some Brazilian researchers for conducting in vitro and in vivo researches. He stated that LLLT has garnered immense recognition for treating soft tissue damage and joint conditions. But, there is a dearth of proof, particularly in vivo proof, regarding the outcome of LLLT in malignant conditions like melanoma. Bjordal and his associates implemented LLT on cancer cultures and on mice that were infused with melanoma  [...]

November 28th, 2009 | Skin Cancer
Penile Cancer
Penile Cancer
Cancer affecting the penis is uncommon and found in nearly four hundred men in the UK annually. It is mostly noted in men past fifty years of age. Penile Cancer Causes The precise reasons for penile cancer occurring is ambiguous. It is less prevalent among men that have had circumcision wherein removal of all or parts of the foreskin have been done subsequent to birth. This could be due the reason that uncircumcised men face difficulty in completely pulling back the foreskin hence leading to improper cleansing of the area beneath it that could harbour HPV or human papilloma virus –the key offender leading to penile warts, additionally raising the risk of developing penile cancer. Few of the skin conditions affecting the penis could progress leading to the development of cancer when ignored.  [...]

November 27th, 2009 | Penile Cancer
Bone Cancer Symptoms And Treatment
Bone Cancer Symptoms And Treatment
Most often bones are the locations of tumors that are the consequence of metastasis of the cancer present in another organ like the breasts, lungs or the prostate. Cancers that originate in the bone such as primary bone cancer are quite rare occurrences. Bone tumors could be benign or malignant in nature. Benign bone tumors are more prevalent, however both kinds could proliferate leading to compression of healthy, normal bone tissue and sop up or substitute it with anomalous tissues. However, benign tumors do not proliferate and are atypically life-menacing. The most prevalent form of bone cancer is osteosarcoma that develops in newly formed tissue present in bones that are still growing. Another form of cancer is chondrosarcoma that develops in the cartilage. Ewing’s sarcoma originates in  [...]

November 25th, 2009 | Bone Cancer
Cervical Cancer Vaccine – Treading Through Past, Present And Future
Cervical Cancer Vaccine – Treading Through Past, Present And Future
Cervical Cancer is a serious health problem affecting women globally. It is the third prevalent kind of cancer in women. Nearly 80% of cervical cancer cases are from developing countries where cervical cancer is the second most prevalent reason behind cancer fatalities among women. The Human Papilloma Virus The finding that the HPV or Human Papillomavirus virus causes cervical cancer has opened novel avenues in its prevention and treatment. There seems to be a strong association between the occurrence of cervical cancer and the commonness of HPV infection in the populace. Above hundred HPV types has been detected, nearly forty are found to affect the genital region and at least fifteen are deemed oncogenic; 2 other types cause majority of the cases of genital warts. HPV linked Diseases Globally,  [...]

November 24th, 2009 | Cervical Cancer
Novel Use Of Umbilical Cord Blood For Reducing Risk Of Leukemia Relapse
Novel Use Of Umbilical Cord Blood For Reducing Risk Of Leukemia Relapse
A novel leukemia research conducted in the Masonic Cancer Center, University of Minnesota reveals that those patients having acute leukemia when administered transplantation of 2 units of UCB or umbilical cord blood had extensive reduction in risk of the disease relapsing. This discovery shows promise in changing the present medical practice of employing a single UCB unit for treating patients having a high risk of relapse of leukemia and other kinds of cancers affecting the blood and bone marrow. Michael Verneris, M.D., and John Wagner, M.D., who have dedicated themselves to the research and treatment of infants having cancer, helmed the research team on this innovative study. The outcomes of this study are printed in the present edition of the medical journal ‘Blood’. This study was backed  [...]

November 24th, 2009 | Blood Cancer
Strong Association Between Folic Acid, B12 Vitamin Treatment And Augmented Cancer Risk, Fatality
Strong Association Between Folic Acid, B12 Vitamin Treatment And Augmented Cancer Risk, Fatality
A study that appeared in the 18th November edition of the ‘JAMA’ revealed that those patients with cardiovascular ailments in Norway – a country having negligible enrichment of foods with folic acid, has a related rise in cancer and fatality due to any reason if they had been given treatment of folic acid and vitamin B12. The background data in the editorial mentions that majority of the epidemiological research have detected converse relations in between folate – a B vitamin and risk of developing colorectal cancer, though these links have been incoherent or lacking for other kinds of cancers. The authors have written that investigational proof indicate that folate shortage could elicit preliminary stages of carcinogenesis, while elevated folic acid dosages could augment spread of  [...]

November 24th, 2009 | News
Gall Bladder Cancer
Gall Bladder Cancer
Cancer affecting the gall bladder is an atypical occurrence with merely around five hundred individuals being detected with this kind of cancer in the United Kingdom annually. It is rarely found in individuals below fifty years of age and is mostly observed in individuals past the age of seventy. It is prevalent in the female gender more than in males. Causes and Probable Risk Factors The reason behind majority of the gall bladder cancers is unclear. There are varied risk factors that could raise the likelihood of developing this form of cancer that include: Gall stones and Inflamed gall bladder Gall bladder cancer more often occurs among individuals that have a past case of gallstones, or among those who have an inflamed gall bladder or cholecystitis. But, majority of the individuals having  [...]

November 23rd, 2009 | Bladder Cancer
Crucial Identification Of Cancer Advancing AEG-1 Gene
Crucial Identification Of Cancer Advancing AEG-1 Gene
Researchers from the Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine have discovered a gene that dons central role in two processes which are critical for the tumor to develop, grow and progress to metastasis. Scientists are hopeful that this discovery would aid in leading to an effectual therapy for targeting and restraining the expression of this gene that would result in hampering cancer growth. The team of researchers have revealed that astrocyte promoted gene-1, AEG-1; a cancer encouraging gene has a decisive role in both oncogenic alteration of a healthy cell into a cancerous one, and angiogenesis that is the development of novel blood cells. Oncogenic change and angiogenesis are essential for the tumor to develop, grow and progress to metastasis. The  [...]

November 23rd, 2009 | News